Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
840 Research Parkway, Suite 546 , Oklahoma City, OK, 73104, US
Bill Humphries brings over 36 years of leadership and business transformation experience in the pharmaceutical and life sciences industries.
By: Charlie Sternberg
Stephen Bardin brings extensive capital raising, corporate development, and strategic finance expertise to the role.
The collaboration aims to ensure the development of infigratinib for children living with achondroplasia, and eventually for other skeletal dysplasias in Japan.
Industry veterans assume key executive positions.
By: Anthony Vecchione
The company has six fill-finish lines that offer a range of configurations, including prefilled syringes, cartridges, and vials.
To support clinical work across its Global Fully Integrated Targeted Therapy (FITT) Strategy.
By: Kristin Brooks
Helsinn gains an exclusive license to commercialize infigratinib in the U.S.
Raether has 20 years of human resources experience within the biotech and medical device industries.
Initiates Phase 1/2a trial of SHP2 inhibitor JAB-3312 in combination with PD-1 antibody Pembrolizumab and MEK inhibitor Binimetinib.
To support development and commercialization of bentracimab.
By: Tim Wright
Nakaya “Nick” Matsumaru joins the company from SymBio Pharmaceuticals.
By: Contract Pharma
To develop and commercialize SHP2 inhibitors targeting a key node in cancer and immune cells.
Deal is designed to accelerate BridgeBio’s gene therapy programs; dedicated suite will support clinical and commercial supply needs.
Greg LaBruyere and Mike Rose join the company’s growing validation team
Mr. Abraham “Avi” Oler will be primarily responsible for business development, investor relations, and legal affairs
By: Betsy Louda
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
